Proportional assist ventilation relieves clinically significant dyspnea in critically ill ventilated patients.
Clinical study
Dyspnea
Mechanical ventilation
Physiology
Journal
Annals of intensive care
ISSN: 2110-5820
Titre abrégé: Ann Intensive Care
Pays: Germany
ID NLM: 101562873
Informations de publication
Date de publication:
17 Dec 2021
17 Dec 2021
Historique:
received:
11
09
2021
accepted:
22
11
2021
entrez:
17
12
2021
pubmed:
18
12
2021
medline:
18
12
2021
Statut:
epublish
Résumé
Dyspnea is common and often severe symptom in mechanically ventilated patients. Proportional assist ventilation (PAV) is an assist ventilatory mode that adjusts the level of assistance to the activity of respiratory muscles. We hypothesized that PAV reduce dyspnea compared to pressure support ventilation (PSV). Mechanically ventilated patients with clinically significant dyspnea were included. Dyspnea intensity was assessed by the Dyspnea-Visual Analog Scale (D-VAS) and the Intensive Care-Respiratory Distress Observation Scale (IC-RDOS) at inclusion (PSV-Baseline), after personalization of ventilator settings in order to minimize dyspnea (PSV-Personalization), and after switch to PAV. Respiratory drive was assessed by record of electromyographic activity of inspiratory muscles, the proportion of asynchrony was analyzed. Thirty-four patients were included (73% males, median age of 66 [57-77] years). The D-VAS score was lower with PSV-Personalization (37 mm [20‒55]) and PAV (31 mm [14‒45]) than with PSV-Baseline (62 mm [28‒76]) (p < 0.05). The IC-RDOS score was lower with PAV (4.2 [2.4‒4.7]) and PSV-Personalization (4.4 [2.4‒4.9]) than with PSV-Baseline (4.8 [4.1‒6.5]) (p < 0.05). The electromyographic activity of parasternal intercostal muscles was lower with PAV and PSV-Personalization than with PSV-Baseline. The asynchrony index was lower with PAV (0% [0‒0.55]) than with PSV-Baseline and PSV-Personalization (0.68% [0‒2.28] and 0.60% [0.31‒1.41], respectively) (p < 0.05). In mechanically ventilated patients exhibiting clinically significant dyspnea with PSV, personalization of PSV settings and PAV results in not different decreased dyspnea and activity of muscles to a similar degree, even though PAV was able to reduce asynchrony more effectively.
Identifiants
pubmed: 34919178
doi: 10.1186/s13613-021-00958-7
pii: 10.1186/s13613-021-00958-7
pmc: PMC8683518
doi:
Types de publication
Journal Article
Langues
eng
Pagination
177Informations de copyright
© 2021. The Author(s).
Références
Clin Chest Med. 2008 Jun;29(2):329-42, vii
pubmed: 18440441
Crit Care Med. 2011 Nov;39(11):2452-7
pubmed: 21705886
Intensive Care Med. 2017 Feb;43(2):184-191
pubmed: 27778044
Am J Respir Crit Care Med. 2008 Jan 15;177(2):170-7
pubmed: 17962636
J Palliat Med. 2010 Mar;13(3):285-90
pubmed: 20078243
Intensive Care Med. 2008 Aug;34(8):1477-86
pubmed: 18437356
Am Rev Respir Dis. 1992 Jan;145(1):121-9
pubmed: 1731574
Ann Intensive Care. 2020 May 29;10(1):67
pubmed: 32472272
Respir Physiol Neurobiol. 2006 Jan 25;150(1):75-81
pubmed: 16448935
Thorax. 2014 Apr;69(4):393-4
pubmed: 24212892
Eur Respir J. 2017 May 25;49(5):
pubmed: 28546267
Am J Respir Crit Care Med. 1997 Jun;155(6):1940-8
pubmed: 9196100
J Pain Symptom Manage. 2013 Dec;46(6):957-63
pubmed: 23608121
Crit Care Med. 2011 Jan;39(1):112-8
pubmed: 21037472
Am J Respir Crit Care Med. 2019 Jun 1;199(11):1302-1304
pubmed: 30562045
Crit Care Med. 2013 Sep;41(9):2125-32
pubmed: 23787397
Crit Care Med. 2006 Aug;34(8):2076-83
pubmed: 16755257
Anesthesiology. 2007 Nov;107(5):746-55
pubmed: 18073550
Am Rev Respir Dis. 1992 Jan;145(1):114-20
pubmed: 1731573
Intensive Care Med. 2006 Jan;32(1):34-47
pubmed: 16283171
Anesthesiology. 2015 Oct;123(4):830-7
pubmed: 26259140
Am J Respir Crit Care Med. 1994 Oct;150(4):896-903
pubmed: 7921460
Crit Care Med. 2012 Jun;40(6):1738-44
pubmed: 22610179
Intensive Care Med. 2015 Apr;41(4):633-41
pubmed: 25693449
Crit Care Med. 2004 Feb;32(2):409-14
pubmed: 14758156
Intensive Care Med. 2004 Mar;30(3):450-5
pubmed: 12961065
J Appl Physiol (1985). 1996 Jul;81(1):426-36
pubmed: 8828695
Intensive Care Med. 2014 Jan;40(1):1-10
pubmed: 24132382
Anesthesiology. 2010 Mar;112(3):670-81
pubmed: 20179505
Eur Respir J. 2014 Jun;43(6):1750-62
pubmed: 24525437
Am J Respir Crit Care Med. 2019 Jun 1;199(11):1377-1384
pubmed: 30485121
Intensive Care Med. 2006 May;32(5):692-9
pubmed: 16523329
COPD. 2005 Mar;2(1):105-10
pubmed: 17136970
Am J Respir Crit Care Med. 2001 Jul 1;164(1):50-60
pubmed: 11435238
Crit Care Med. 2014 Jan;42(1):74-82
pubmed: 23982026
Crit Care Med. 2011 Sep;39(9):2059-65
pubmed: 21572329
Intensive Care Med. 2013 Aug;39(8):1368-76
pubmed: 23575612
Crit Care Med. 2008 Nov;36(11):3019-23
pubmed: 18824913
Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1471-8
pubmed: 9817695
Crit Care. 2013 Oct 16;17(5):R239
pubmed: 24131701
J Appl Physiol Respir Environ Exerc Physiol. 1981 Sep;51(3):557-64
pubmed: 7327955
Intensive Care Med. 2013 Jun;39(6):1040-7
pubmed: 23417203
Clin Intensive Care. 1995;6(2):57-61
pubmed: 10150800
Crit Care Med. 2002 Apr;30(4):746-52
pubmed: 11940739
Intensive Care Med. 2006 Oct;32(10):1515-22
pubmed: 16896854
Intensive Care Med. 2014 Feb;40(2):235-48
pubmed: 24275901
Am J Respir Crit Care Med. 1997 Apr;155(4):1341-8
pubmed: 9105077